Alzamend Neuro Files Prospectus Related To The Resale Of Up To 98.4M Common Shares By Selling Stockholder
-SEC Filing
Read original at benzingaStocks · News reference
Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts changed outlook on top names. Piper Sandler raises Mercury Systems' target price, Ascendiant Capital boosts Alzamend Neuro's target price, BTIG raises Henry Schein's target price, Cantor Fitzgerald increases Palo Alto's target price, Morgan Stanley cuts Baidu's target price, Cantor Fitzgerald slashes Crowdstrike Holdings' target price, Baird raises Donaldson Company's target price, B of A Securities cuts Pony AI's target price.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 19, 2026, 12:23 PM
- Checked
- Aug 19, 2026, 12:23 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Alzamend Neuro Announces Its Abstract On Resting-State Functional Magnetic Resonance Imaging Findings For AL001 Accepted For Presentation At Neuroscience 2026
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar
Read original at benzingaAscendiant Capital Maintains Buy on Alzamend Neuro, Raises Price Target to $26
Ascendiant Capital analyst Edward Woo maintains Alzamend Neuro (NASDAQ:ALZN) with a Buy and raises the price target from $25 to $26.
Read original at benzingaBrokers Suggest Investing in Baidu Inc. (BIDU): Read This Before Placing a Bet
While brokers maintain a strong buy recommendation for Baidu Inc. with an average brokerage recommendation of 1.65, the Zacks Rank system assigns it a Strong Sell rating due to a 19.3% decline in consensus earnings estimates over the past month. The article cautions that brokerage recommendations often carry positive bias and may not accurately predict stock performance, suggesting investors should rely on earnings estimate revisions rather than broker sentiment.
Read original at zacks-investment-researchBaidu shares are trading higher after the company announced it will become a dual-primary listed company on the Hong Kong Stock Exchange in Hong Kong SAR and the Nasdaq Global Select Market in the United States.
Read original at benzingaBaidu To Become Dual-Primary Listed On Hong Kong Stock Exchange And Nasdaq Effective Sept. 1, 2026; No New Share Issuance Or Fundraising
Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today announced that the Company's
Read original at benzinga